Inhibitory Effect of Curcumin on MDR1 Gene Expression in Patient Leukemic Cells

  • Anuchapreeda, Songyot (Division of Clinical Microscopy, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University) ;
  • Thanarattanakorn, Pattra (Department of Pediatrics, Faculty of Medicine, Chiang Mai University) ;
  • Sittipreechacharn, Somjai (Department of Pediatrics, Faculty of Medicine, Chiang Mai University) ;
  • Tima, Singkome (Division of Clinica Microscopy, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University) ;
  • Chanarat, Prasit (Division of Clinical Microscopy, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University) ;
  • Limtrakul, Pornngarm (Department of Biochemistry, Faculty of Medicine, Chiang Mai University)
  • 발행 : 2006.10.01

초록

When patients with cancers are treated with chemotherapeutic agents a long time, some of the cancer cells develop the multidrug resistance (MDR) phenotype. MDR cancer cells are characterized by the overexpression of multidrug resistance1 (MDR1) gene which encodes P-glycoprotein (Pgp), a surface protein of tumor cells that functions to produce an excessive efflux and thereby an insufficient intracellular concentration of chemotherapeutic agents. A variety of studies have sought potent MDR modulators to decrease MDR1 gene expression in cancer cells. Our previous study has shown that curcumin exhibits characteristics of a MDR modulator in KB-V1 multidrug-resistant cells. The aim of this study was to further investigate the effect of curcumin on MDR1 gene expression in patient leukemic cells. The leukemic cells were collected from 78 childhood leukemia patients admitted at Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand, in the period from July 2003 to February 2005. There were 61 cases of acute lymphoblastic leukemia (ALL), 14 cases of acute myeloblastic leukemia (AML), and 3 cases of chronic myelocytic leukemia (CML). There were 47 males and 31 females ranging from 1 to 15 years old. Bone marrows were collected. The leukemic cells were separated and cultured in the presence or absence of $10{\mu}M$ curcumin for 48 hours. MDR1 mRNA levels were determined by RT-PCR. It was found that curcumin reduced MDR1 gene expression in the cells from 33 patients (42%). Curcumin affected the MDR1 gene expression in 5 of 11 relapsed cases (45%), 10 of 26 cases of drug maintenance (38%), 7 of 18 cases of completed treatment (39%), and 11 of 23 cases of new patients (48%). The expression levels of MDR1 gene in leukemic patient cells as compared to that of KB-V1 cells were classified as low level (1-20%) in 5 of 20 cases (25%), medium level (21-60%) in 14 of 32 cases (44%), and high level (61-100%) in 14 of 20 cases (70%). In summary, curcumin decreased MDR1 mRNA level in patient leukemic cells, especially in high level of MDR1 gene groups. Thus, curcumin treatment may provide a lead for clinical treatment of leukemia patients in the future.

키워드

참고문헌

  1. Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I., and Gottesman, M. M., Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol., 39, 361-398 (1999) https://doi.org/10.1146/annurev.pharmtox.39.1.361
  2. Ammon, H. P., Safayhi, H., Mack, T., and Sabieraj, J., Mechanism of anti-inflammatory actions of curcumin and boswellic acids. J. Ethnopharmacol., 38,113-119 (1993) https://doi.org/10.1016/0378-8741(93)90006-Q
  3. Anuchapreeda, S., Leechanachai, P., Smith, M., Ambudkar, S. V., and Limtrakul, P., Modulation of P-glycoprotein expression and function by curcumin in multidrug resistance human KB cells. Biochem. Pharmacol., 64, 573-582 (2002) https://doi.org/10.1016/S0006-2952(02)01224-8
  4. Anuchapreeda, S., Muangmoonchai, R., and Limtrakul, P., Effect of curcuminoids on MDR-1 gene promoter activity in human cervical carcinoma cells. Chiang Mai Med Bull., 41, 189-203 (2002)
  5. Anuchapreeda, S., Thanarattanakorn, P., Sittipreechacharn, S., Chanarat, P., and Limtrakul, P., Curcumin inhibits WT1 gene expression in human leukemic K562 cells. Acta. Pharmacologicol. Sinica., 27, 360-366 (2006) https://doi.org/10.1111/j.1745-7254.2006.00291.x
  6. Anuchapreeda, S., Limtrakul, P., Thanarattanakorn, P., Sittipreechacharn, S., and Chanarat, P., Inhibitory effect of curcumin on WT1 gene expression in patient leukemic cells. Arch. Pharm. Res., 29, 80-87 (2006) https://doi.org/10.1007/BF02977473
  7. Asai, A., Nakagawa, K., and Miyazawa, T., Antioxidative effects of turmeric, rosemary and capsicum extracts on membrane phospholipid peroxidation and liver lipid metabolism in mice. Biosci. Biotechnol. Biochem., 63, 2118-2122 (1999) https://doi.org/10.1271/bbb.63.2118
  8. Azuine, M. A. and Bhide, S. V., Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in swiss mice. Nutr. Cancer., 17, 77-83 (1992) https://doi.org/10.1080/01635589209514174
  9. Banerjee, A. and Nigam S. S., Antimicrobial efficacy of the essential of Curcuma longa. Indian. J. Med. Res., 68, 864- 866 (1978)
  10. Bielak-Zmijewska, A., Koronkiewicz, M., Skierski, J., Piwocka, K., Radziszewska, E., and Sikora, E., Effect of curcumin on the apoptosis of rodent and human nonproliferating and proliferating lymphoid cells. Nutr. Cancer., 38, 131-138 (2000) https://doi.org/10.1207/S15327914NC381_18
  11. Bourhis, J., Benard, J., Hartmann, O., Boccon-Gibod, L., Lemerle, J., and Riou, G., Correlation of mdr1 gene expression with chemotherapy in neuroblastoma. J. Natl. Cancer Inst., 81, 11401-11405 (1989)
  12. Chan, H. S. L., Thorner, P. S., Haddad, G., and Ling, V., Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft-tissue sarcoma of childhood. J. Clin. Oncol., 8, 689-704 (1990) https://doi.org/10.1200/JCO.1990.8.4.689
  13. Chearwae, W., Anuchapreeda, S., Nandigama, K., Ambudkar, S. V., and Limtrakul, P., Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcuminI, II, and III purified from Turmeric powder. Biochem. Pharmacol., 68, 2043-2052 (2004) https://doi.org/10.1016/j.bcp.2004.07.009
  14. Dorai, T., Cao, Y. C., Buttyan, R., and Katz, A. E., Therapeutic potential of curcumin in human postate cancer III. Curcumin inhibits proliferation induces apoptosis and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate, 47, 293-303 (2001) https://doi.org/10.1002/pros.1074
  15. Fitzpatrick, F., Plant substances active against Mycobacterium tuberculosis. Antibiot. Chemother., 4, 528-536 (1954)
  16. Fujimaki, S., Funato, T., Harigae, H., Fujiwara, J., Kameoka, J., Megura, K., Kaku, M., and Sasaki, T., Quantitative analysis of a MDR1 transcript for prediction of drug resistance in acute leukemia. Clin. Chem., 48, 811-817 (2002)
  17. Hayashi, T., Kobayashi, H., Miyashi, H., Ohshima, T., Ujiiye, T., Kawase, M., Hotta, T., and Takemura, Y., A competitive nucleic acid sequence-based amplification assay for the quantification of human MDR1 transcript in leukemia cells. Clinica. Chimica. Acta., 342, 115-126 (2004) https://doi.org/10.1016/j.cccn.2003.12.013
  18. Huang, H. C., Jan, T. R., and Yeh, S. F., Inhibitory effect of curcumin, an anti-inflamatory agent, on vascular smooth muscle cell proliferation. Eur. J. Pharmacol., 221, 381-384 (1992) https://doi.org/10.1016/0014-2999(92)90727-L
  19. Kunchandy, E. and Rao, M. N. A., Oxygen radical scarvenging activity of curcumin. Int. J. Pharm., 58, 237-240 (1990) https://doi.org/10.1016/0378-5173(90)90201-E
  20. Kuo, M. L., Huang, T. S., and Lin, J. K., Curcumin, an antioxidant and antitumor promoter, induces apoptosis in human leukemia cells. Biochim. Biophys. Acta., 1317, 95-100 (1996) https://doi.org/10.1016/S0925-4439(96)00032-4
  21. Limtrakul, P., Anuchapreeda, S., and Buddhasukh, D., Modulation of human multidrug resistance MDR-1 gene by natural curcuminoids. BMC Cancer, 4, 1-6 (2004) https://doi.org/10.1186/1471-2407-4-1
  22. Limtrakul, P., Anuchapreeda, S., Lipigorngoson, S., and Dunn F. W., Inhibition of carcinogen induced c-Ha-ras and c-fos proto-oncogenes expression by dietary curcumin. BMC Cancer, 1, 1-7 (2001) https://doi.org/10.1186/1471-2407-1-1
  23. Limtrakul, P., Lipigorngoson, S., Namwong, O., Apisariyakul, A., and Dunn, F. W., Inhibitory effect of dietary curcumin on skin carcinogenesis in mice. Cancer Lett., 116, 197-203 (1997) https://doi.org/10.1016/S0304-3835(97)00187-0
  24. Lorvidhaya, V. and Srisukho, S., Annual report 1999; Chiang Mai Cancer registry, Academic-Publishing Unit, Faculty of Medicine, Chiang Mai University: Chiang Mai., 23, 51p, (2002)
  25. Mickley, L. A., Lee, J. S., Weng, Z., Zhan, Z., Alvarez, M., Wilson, W., Bates, S. E., and Fojo, T., Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug selected cell lines and human tumors. Blood, 91, 1749-1756 (1998)
  26. Mohan, R., Ashton, P., Russo, L. A., Pham, B. Q., Kasahara, N., Raizman, M. B., and Fini, M. E., Curcuminoid inhibit the angiogenic response stimulated by fibroblast growth factor-2, inducing expression of matrix metalloproteinase gelatinase B. J. Biol. Chem., 275, 10405-10412 (1998) https://doi.org/10.1074/jbc.275.14.10405
  27. Murphy, L. D., Herzog, C. E., Rudick, J. B., Fojo, A. J., and Bates, S. E., Use of polymerase chain reaction in the quantitation of mdr1 Gene Expression. Biochemistry, 29, 10351-10356 (1990) https://doi.org/10.1021/bi00497a009
  28. Nagabhushan, M., Amonkar, A. J., and Bhide, S. V., In vitro antimutagenicity of curcumin against environmental mutagens. Food Chem. Toxicol., 25, 545-547 (1987) https://doi.org/10.1016/0278-6915(87)90207-9
  29. Noonan, K. E., Beck, C., Holzmayer, T. A., Chin, J. E., Wunder, J. S., Andrulis, I. L., Gazdar, A. F., Willman, C. L., Griffith, B., Von Hoff, D. D., and Roninson, I. B., Quantitative analysis of mdr1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. Natl. Acad. Sci. USA., 87, 7160-7164 (1990)
  30. Patii, T. N. and Srinivasan, M., Hypochlolesteremic effect of curcumin in induced hypercholesteremic rats. Indian. J. Exp. Biol., 9, 167-169 (1971)
  31. Piwocha, K., Bielak-Mijewska, A., and Sikora, E., Curcumin induces caspase-3-indepencent apoptosis in human multidrug-resistant cells. Ann. N.Y. Acad. Sci., 973, 250-254 (2002) https://doi.org/10.1111/j.1749-6632.2002.tb04643.x
  32. Polasa, K., Raghuram, T. C., Krishna, T. P., and Krishnaswamy, K., Effect of turmeric on urinary mutagens in smokers. Mutagenesis, 7, 107-109 (1992) https://doi.org/10.1093/mutage/7.2.107
  33. Rao, C. V., Rivenson, A., Simi, B., and Reddy, B. S., Chemoprevention of colon cancer by dietary curcumin. Ann. N.Y. Acad. Sci., 768, 201-204 (1995) https://doi.org/10.1111/j.1749-6632.1995.tb12122.x
  34. Rao, D. S., Kekhara, N. C., Satyanarayana, M. N., and Srinivasan, M., Effect of curcumin on serum and liver cholesterol levels in the rat. J. Nutr., 100, 1307-1315 (1970) https://doi.org/10.1017/S0007114508971336
  35. Romiti, N., Tongiani, R., Cervelli, F., and Chiell, E., Effect of curcumin on P-glycoprotein in primary cultures of rat hepatocytes. Life Sci., 62, 2349-2358 (1998) https://doi.org/10.1016/S0024-3205(98)00216-1
  36. Roy, R. G., Madesayaa, N. M., Ghosh, R. B., Gopalakrishnan, D. V., Murthy, N. N., Dorairaj, T. J., and Sitaraman, N. L., Study on inhalation therapy and indigenous compound on P. vivax and P. falciparum infections; a preliminary communication. Indian. J. Med. Res., 64, 1451-1455 (1976)
  37. Ruby, A. J., Kuttan, G., Babu, K. D., Rajasekharan, K. N., and Kuttan, R., Anti-tumor and antioxidant activity of natural curcuminoids. Cancer Lett., 94, 79-83 (1995) https://doi.org/10.1016/0304-3835(95)03827-J
  38. Salirnath, B. P., Sundaresh, C. S., and Srinivas, L., Dietary compnents inhibit lipid peroxidation in erythrocyte membrane. Nutr. Res., 6, 1171-1178 (1989) https://doi.org/10.1016/S0271-5317(86)80087-2
  39. Soudamini, K. K. and Kuttan, R., Inhibition of chemical carcinogenesis by curcumin. J. Ethnopharmacol., 27, 227-233 (1989) https://doi.org/10.1016/0378-8741(89)90094-9
  40. Sawada, T., Yamahara, J., Shimazu, S., and Ohta, T., Evaluation of crude drugs by bioassay. III. Comparison local variation of contents and the fungistatic action of the essential oil from the root of Curcuma longa. Shoyakugaku Zasshi, 25, 11-16 (1971)
  41. Schoenlein, P. V., Shen, D. W., Barrett, J. T., Pastan, I., and Gottesman, M. M., Double minute chromosomes carrying the human multidrug resistance1 and 2 genes are generated from the dimerization of submicroscopic circular DNAs in colchicines selected KB carcinoma cells. Mol. Biol. Cell, 3, 507-520 (1992) https://doi.org/10.1091/mbc.3.5.507
  42. Schwarzenbach, H., A diagnostic tool for monitoring multidrug resistance expression in human tumor tissues. Anal. Biochem., 308, 26-33 (2002) https://doi.org/10.1016/S0003-2697(02)00228-2
  43. Selvam, R., Subramanian, L., Gayathri, R., and Angayarkanni, N., The antioxidant activity of turmeric (Curcuma longa). J. Ethnopharmacol., 47, 59-67 (1995) https://doi.org/10.1016/0378-8741(95)01250-H
  44. Shankar, T. N. B. and Murthy, V. S., Effect of turmeric (Curcuma longa) on the growth of some intestinal bacteria in vitro. J. Food Sci. Technol., 15, 152-153 (1978)
  45. Singh, S. V., Hu, X., Srivastava, S. K., Sigh, M., Xia, H., Orchard, J. L., and Zaren, H. A., Mechanism of inhibition of benzo[a] pyrene-induced forestomach cancer in mice by dietary curcumin. Carcinogenesis, 19, 1357-1360 (1998) https://doi.org/10.1093/carcin/19.8.1357
  46. Sreejayan, Rao, M. N., Curcuminoids as potent inhibitors of lipid peroxidation. J. Pharm. Pharmacol., 46, 1013-1016 (1994) https://doi.org/10.1111/j.2042-7158.1994.tb03258.x
  47. Sriplung, H., Sontipong, S., Martin, N., Wiangnon, S., Vootipong, V., Cheirsilpa, A., Kanchanabat, C., and Khuhaprema, T., Cancer in Thailand. Bangkok; Medical Publisher: Bangkok, 3, Chapter II, pp. 66-69, (2003)
  48. Waiwut, P., Anuchapreeda, S., and Limtrakul, P., Curcumin inhibits the P-glycoprotein level in carcinoma of cervix cells (KB-carcinoma cell lines) induced by vinblastine. Chiang Mai Med. Bull., 41, 139-145 (2002)